FDA NDC Directory · JSON-LD · Markdown

Deferasirox oral

NDC 67877-677 · HUMAN PRESCRIPTION DRUG · GRANULE

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA213374
Dosage form / routeGRANULE · ORAL
Active ingredientsDEFERASIROX (360 mg/1)
Marketing started20200716
Package count1

External sources

Source: openFDA. Public-domain (CC0).